+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Association between rheumatoid arthritis disease activity, progression of functional limitation and long-term risk of orthopaedic surgery: combined analysis of two prospective cohorts supports EULAR treat to target DAS thresholds



Association between rheumatoid arthritis disease activity, progression of functional limitation and long-term risk of orthopaedic surgery: combined analysis of two prospective cohorts supports EULAR treat to target DAS thresholds



Annals of the Rheumatic Diseases 75(12): 2080-2086



To examine the association between disease activity in early rheumatoid arthritis (RA), functional limitation and long-term orthopaedic episodes. Health Assessment Questionnaire (HAQ) disability scores were collected from two longitudinal early RA inception cohorts in routine care; Early Rheumatoid Arthritis Study and Early Rheumatoid Arthritis Network from 1986 to 2012. The incidence of major and intermediate orthopaedic surgical episodes over 25 years was collected from national data sets. Disease activity was categorised by mean disease activity score (DAS28) annually between years 1 and 5; remission (RDAS≤2.6), low (LDAS>2.6-3.2), low-moderate (LMDAS≥3.2-4.19), high-moderate (HMDAS 4.2-5.1) and high (HDAS>5.1). Data from 2045 patients were analysed. Patients in RDAS showed no HAQ progression over 5 years, whereas there was a significant relationship between rising DAS28 category and HAQ at 1 year, and the rate of HAQ progression between years 1 and 5. During 27 986 person-years follow-up, 392 intermediate and 591 major surgeries were observed. Compared with the RDAS category, there was a significantly increased cumulative incidence of intermediate surgery in HDAS (OR 2.59 CI 1.49 to 4.52) and HMDAS (OR 1.8 CI 1.05 to 3.11) categories, and for major surgery in HDAS (OR 2.48 CI 1.5 to 4.11), HMDAS (OR 2.16 CI 1.32 to 3.52) and LMDAS (OR 2.07 CI 1.28 to 3.33) categories. There was no significant difference in HAQ progression or orthopaedic episodes between RDAS and LDAS categories. There is an association between disease activity and both poor function and long-term orthopaedic episodes. This illustrates the far from benign consequences of persistent moderate disease activity, and supports European League Against Rheumatism treat to target recommendations to secure low disease activity or remission in all patients.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057251208

Download citation: RISBibTeXText

PMID: 26979104

DOI: 10.1136/annrheumdis-2015-208669


Related references

The association of obesity with disease activity, functional ability and quality of life in early rheumatoid arthritis: data from the Early Rheumatoid Arthritis Study/Early Rheumatoid Arthritis Network UK prospective cohorts. Rheumatology 2018, 2018

THU0063Outcomes of Treat-To-Target Strategy in Established Rheumatoid Arthritis: A Long-Term Prospective Cohort Study. Annals of the Rheumatic Diseases 75(Suppl 2): 200.3-201, 2016

Characteristics of functional impairment in patients with long-standing rheumatoid arthritis based on range of motion of joints: Baseline data from a multicenter prospective observational cohort study to evaluate the effectiveness of joint surgery in the treat-to-target era. Modern Rheumatology 28(3): 474-481, 2017

Long-term outcomes of treat-to-target strategy in established rheumatoid arthritis: a daily practice prospective cohort study. Rheumatology International 37(6): 993-997, 2017

Have radiographic progression rates in early rheumatoid arthritis changed? A systematic review and meta-analysis of long-term cohorts. Rheumatology 2016, 2016

An analysis of the ability of serum AST to predict changes in liver histopathology in patients with rheumatoid arthritis on MTX A prospective study combining data from 3 long-term cohorts. Arthritis & Rheumatism 37(9 Suppl. ): S361, 1994

Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trial. Rmd Open 4(2): E000752-E000752, 2018

Effect of Magnetic Resonance Imaging vs Conventional Treat-to-Target Strategies on Disease Activity Remission and Radiographic Progression in Rheumatoid Arthritis: The IMAGINE-RA Randomized Clinical Trial. JAMA 321(5): 461-472, 2019

Long-term disease and patient-reported outcomes of a continuous treat-to-target approach in patients with early rheumatoid arthritis in daily clinical practice. Clinical Rheumatology 37(5): 1189-1197, 2018

AB0325Treating rheumatoid arthritis to target: Improvement of disease activity in patients with disease applying treat to target recommendations. Annals of the Rheumatic Diseases 71(Suppl 3): 656.6-656, 2013

Long-term physical activity and subsequent risk for rheumatoid arthritis among women: A prospective cohort study. Arthritis and Rheumatology 2019, 2019

Impact of a magnetic resonance imaging-guided treat-to-target strategy on disease activity and progression in patients with rheumatoid arthritis (the IMAGINE-RA trial): study protocol for a randomized controlled trial. Trials 16: 178, 2016

SAT0088Prognostic Factors Toward Rapid Radiographic Progression in Patients with Rheumatoid Arthritis in Clinical Practice: A Japanese Multicenter, Prospective Longitudinal Cohort Study for Achieving Treat to Target Strategy. Annals of the Rheumatic Diseases 74(Suppl 2): 680.2-680, 2015

OP0307No Long-Term Effect on Disease Activity and Pain of Physical Activity Found in Prospective Observational Study of Early Rheumatoid Arthritis. Annals of the Rheumatic Diseases 75(Suppl 2): 174.1-174, 2016

Long-term results of multiple synovectomy for patients with refractory rheumatoid arthritis. Effects on disease activity and radiological progression. Clinical and Experimental Rheumatology 22(2): 151-157, 2004